STOCK TITAN

Small Becton Dickinson (NYSE: BDX) insider Rule 144 sale and recent 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Becton, Dickinson and Company (BDX) insider files a Form 144 to sell a small block of shares under an existing trading plan. The notice covers a proposed sale of 75 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 01/26/2026. The filing states an aggregate market value of 15134.25 for these 75 shares, compared with 285418551 shares of common stock outstanding.

The securities to be sold were acquired as restricted stock units from the issuer on 08/20/2025, in an amount of 75 shares. The form also lists prior Rule 10b5-1 sales for Michael Feld over the past three months, including 74, 75, and 57 common shares sold on 12/26/2025, 12/01/2025, and 10/27/2025, respectively, with disclosed gross proceeds for each transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the BDX Form 144 filing by Michael Feld disclose?

The filing discloses an intended sale of 75 shares of Becton, Dickinson and Company common stock under Rule 144, to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 01/26/2026.

How many BDX shares are planned to be sold under this Form 144 notice?

The notice covers a proposed sale of 75 shares of Becton, Dickinson and Company common stock, with an aggregate market value listed as 15134.25.

How many BDX shares are outstanding compared to the shares in this Form 144?

The Form 144 lists 285418551 shares of Becton, Dickinson and Company common stock outstanding, compared to the 75 shares covered by this notice.

How and when were the BDX shares in this Form 144 acquired?

The 75 shares were acquired as restricted stock units from the issuer on 08/20/2025, with the amount of securities acquired and the payment date both shown as 75 shares and 08/20/2025, respectively.

What prior BDX stock sales under Rule 10b5-1 are disclosed for Michael Feld?

The notice lists prior 10b5-1 sales for Michael Feld: 74 common shares on 12/26/2025 for gross proceeds of 14509.92, 75 shares on 12/01/2025 for 14502.00, and 57 shares on 10/27/2025 for 10602.57.

Which broker is handling the BDX shares in this Form 144 filing?

The broker named is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the seller make in the BDX Form 144 notice?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current and prospective operations that has not been publicly disclosed.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

57.49B
283.77M
0.57%
92.26%
1.59%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES